Slideshow
Author(s):
New technology may help patients and providers assess changes in severity of Parkinson disease symptoms more objectively.
NeuroVoices: Sushma Kola, MD, on Integrative Approaches and Research Developments for Neurology Care in 2025
Episode 132: Aiding Diagnosis of Synucleinopathies Through SAAmplify-aSYN Biomarker Test
FDA Approves Apomorphine Infusion Device SPN-830 as New Parkinson Treatment
Neurology Unwrapped: 2024’s Most Intriguing Conversations
Advancing Neurology Through Compassion and Innovation: Insights from Dr. Hubble
Multiple System Atrophy Agent ATH434 Shows Promising Topline Efficacy in Phase 2 Trial